EARO

EDDC launched its Fee-for-Service initiative, the EDDC Academic Research Organisation (EARO), in late 2020. This endeavour is part of EDDC's larger goal of facilitating the translation of lab science into commercial assets in Singapore, by engaging local biotech, biopharma, and public-funded research groups... EARO aims to drive the innovation and advancement of translational drug discovery in Singapore and to enable our scientific community to do so cost-effectively by providing access to EDDC's specialised technologies, expertise, and connections... EDDC aims to develop innovative therapeutics and companion diagnostics that have the potential to improve and save the lives of patients in Singapore and beyond. We want to advance the development of safe and effective therapies that address unmet medical needs.

Also known as: Experimental Drug Development Centre

Primary location: Singapore